21 May 2010
Dr Kirpensteijn begins his two-year term as WSAVA president in June. Like his predecessor David Wadsworth, he wants to improve the way the organization is run, enabling it to do more and reach further.
In his ‘day job’ he is a professor of soft tissue surgery at Utrecht University. His involvement ...
16 April 2010
Dr
Alexander Jahn
, head of Region International at Bayer Animal Health, casually mentioned that he was somewhat unprepared for the biting cold in China on his recent visit there, a stark contrast to the muggy heat in Mumbai, India.
The growing animal health markets of the two nations are vastly ...
26 March 2010
The Novartis Venture Fund started life in 1996 after the merger of Ciba and Sandoz . It was originally conceived only as a temporary instrument, but its focus on biotech became successful and gave the fund longevity.
“With a mixture of luck and knowledge, we had success from investing in a couple ...
19 March 2010
What an animal health company chooses to focus its R&D efforts on depends on several factors. France-based Merial , for example, has set out a strategy to exploit the companion animal sector as one of its priorities – especially in antiparasitics and biologicals.
“That is where our strategy and ...
26 February 2010
Intervet/Schering-Plough Animal Health (I/SPAH)'s new president in Brazil,
Vilson Simon
, wants to make his company grow in 2010. More specifically, his target is to twice outperform the market, as he told Animal Pharm. “In 2010, the Brazilian market for veterinary products is expected to grow by ...
